Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Unresectable or Metastatic PDGFRA Exon 18
.
Show all posts
Showing posts with label
Unresectable or Metastatic PDGFRA Exon 18
.
Show all posts
Thursday, March 19, 2020
FDA Approves Ayvakit (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor
›
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and ...
›
Home
View web version
